[Beta-blockaders and angina pectoris].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D000818:Animals; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D011217:Practolol / Q000008:administration & dosage; D011433:Propranolol / Q000097:blood / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D013329:Structure-Activity Relationship
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D011433:Propranolol; D007545:Isoproterenol; D011217:Practolol; D009638:Norepinephrine; D004837:Epinephrine
Bêta-bloquants et angine de poitrine.